nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—diaphragm—sarcoma	0.265	0.327	CbGeAlD
Cyclopentolate—CHRM3—muscle of abdomen—sarcoma	0.26	0.321	CbGeAlD
Cyclopentolate—BCHE—myometrium—sarcoma	0.0322	0.0397	CbGeAlD
Cyclopentolate—CHRM3—smooth muscle tissue—sarcoma	0.0298	0.0368	CbGeAlD
Cyclopentolate—BCHE—seminal vesicle—sarcoma	0.0291	0.0359	CbGeAlD
Cyclopentolate—BCHE—hematopoietic system—sarcoma	0.0276	0.0341	CbGeAlD
Cyclopentolate—BCHE—smooth muscle tissue—sarcoma	0.0243	0.03	CbGeAlD
Cyclopentolate—BCHE—skin of body—sarcoma	0.024	0.0297	CbGeAlD
Cyclopentolate—BCHE—cardiac atrium—sarcoma	0.021	0.0259	CbGeAlD
Cyclopentolate—BCHE—uterus—sarcoma	0.0209	0.0258	CbGeAlD
Cyclopentolate—CHRM3—testis—sarcoma	0.0185	0.0229	CbGeAlD
Cyclopentolate—BCHE—bone marrow—sarcoma	0.0177	0.0219	CbGeAlD
Cyclopentolate—BCHE—testis—sarcoma	0.0151	0.0187	CbGeAlD
Cyclopentolate—BCHE—liver—sarcoma	0.0143	0.0177	CbGeAlD
Cyclopentolate—BCHE—lymph node—sarcoma	0.011	0.0135	CbGeAlD
Cyclopentolate—Paralysis—Vincristine—sarcoma	0.00879	0.0462	CcSEcCtD
Cyclopentolate—Photophobia—Thiotepa—sarcoma	0.00647	0.034	CcSEcCtD
Cyclopentolate—Coma—Vincristine—sarcoma	0.00558	0.0294	CcSEcCtD
Cyclopentolate—Urinary retention—Thiotepa—sarcoma	0.00475	0.025	CcSEcCtD
Cyclopentolate—Lacrimation—Epirubicin—sarcoma	0.00472	0.0248	CcSEcCtD
Cyclopentolate—Ataxia—Thiotepa—sarcoma	0.0047	0.0247	CcSEcCtD
Cyclopentolate—Lacrimation—Doxorubicin—sarcoma	0.00436	0.023	CcSEcCtD
Cyclopentolate—Urinary retention—Vincristine—sarcoma	0.00421	0.0222	CcSEcCtD
Cyclopentolate—Ataxia—Vincristine—sarcoma	0.00417	0.0219	CcSEcCtD
Cyclopentolate—Paralysis—Epirubicin—sarcoma	0.00399	0.021	CcSEcCtD
Cyclopentolate—Conjunctivitis—Thiotepa—sarcoma	0.00374	0.0197	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—sarcoma	0.00369	0.0194	CcSEcCtD
Cyclopentolate—Hallucination—Thiotepa—sarcoma	0.00344	0.0181	CcSEcCtD
Cyclopentolate—Drowsiness—Mitoxantrone—sarcoma	0.00333	0.0175	CcSEcCtD
Cyclopentolate—Conjunctivitis—Mitoxantrone—sarcoma	0.00323	0.017	CcSEcCtD
Cyclopentolate—Flushing—Dactinomycin—sarcoma	0.00319	0.0168	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Epirubicin—sarcoma	0.00316	0.0166	CcSEcCtD
Cyclopentolate—Vasodilation—Epirubicin—sarcoma	0.00316	0.0166	CcSEcCtD
Cyclopentolate—Hallucination—Vincristine—sarcoma	0.00305	0.0161	CcSEcCtD
Cyclopentolate—Lacrimation increased—Epirubicin—sarcoma	0.00301	0.0158	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—sarcoma	0.00292	0.0154	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—sarcoma	0.00292	0.0154	CcSEcCtD
Cyclopentolate—Vision blurred—Thiotepa—sarcoma	0.00284	0.0149	CcSEcCtD
Cyclopentolate—Coordination abnormal—Epirubicin—sarcoma	0.00282	0.0149	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—sarcoma	0.00278	0.0146	CcSEcCtD
Cyclopentolate—Agitation—Thiotepa—sarcoma	0.00277	0.0146	CcSEcCtD
Cyclopentolate—Coordination abnormal—Doxorubicin—sarcoma	0.00261	0.0137	CcSEcCtD
Cyclopentolate—Convulsion—Thiotepa—sarcoma	0.00261	0.0137	CcSEcCtD
Cyclopentolate—Coma—Epirubicin—sarcoma	0.00253	0.0133	CcSEcCtD
Cyclopentolate—Agitation—Vincristine—sarcoma	0.00245	0.0129	CcSEcCtD
Cyclopentolate—Vision blurred—Mitoxantrone—sarcoma	0.00245	0.0129	CcSEcCtD
Cyclopentolate—Vertigo—Vincristine—sarcoma	0.0024	0.0126	CcSEcCtD
Cyclopentolate—Tachycardia—Thiotepa—sarcoma	0.0024	0.0126	CcSEcCtD
Cyclopentolate—Coma—Doxorubicin—sarcoma	0.00234	0.0123	CcSEcCtD
Cyclopentolate—Convulsion—Vincristine—sarcoma	0.00231	0.0122	CcSEcCtD
Cyclopentolate—Flushing—Etoposide—sarcoma	0.00231	0.0121	CcSEcCtD
Cyclopentolate—Convulsion—Mitoxantrone—sarcoma	0.00225	0.0119	CcSEcCtD
Cyclopentolate—Somnolence—Thiotepa—sarcoma	0.00218	0.0115	CcSEcCtD
Cyclopentolate—Tachycardia—Mitoxantrone—sarcoma	0.00207	0.0109	CcSEcCtD
Cyclopentolate—Vertigo—Etoposide—sarcoma	0.00194	0.0102	CcSEcCtD
Cyclopentolate—Ataxia—Epirubicin—sarcoma	0.00189	0.00996	CcSEcCtD
Cyclopentolate—Somnolence—Mitoxantrone—sarcoma	0.00189	0.00992	CcSEcCtD
Cyclopentolate—Convulsion—Etoposide—sarcoma	0.00187	0.00986	CcSEcCtD
Cyclopentolate—Abdominal distension—Epirubicin—sarcoma	0.00175	0.00921	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—sarcoma	0.00175	0.00921	CcSEcCtD
Cyclopentolate—Pruritus—Thiotepa—sarcoma	0.00174	0.00914	CcSEcCtD
Cyclopentolate—Tachycardia—Etoposide—sarcoma	0.00172	0.00906	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—sarcoma	0.00162	0.00853	CcSEcCtD
Cyclopentolate—Somnolence—Etoposide—sarcoma	0.00157	0.00825	CcSEcCtD
Cyclopentolate—Drowsiness—Epirubicin—sarcoma	0.00155	0.00816	CcSEcCtD
Cyclopentolate—Rash—Thiotepa—sarcoma	0.00155	0.00815	CcSEcCtD
Cyclopentolate—Dermatitis—Thiotepa—sarcoma	0.00155	0.00814	CcSEcCtD
Cyclopentolate—Rash—Dactinomycin—sarcoma	0.00154	0.00809	CcSEcCtD
Cyclopentolate—Conjunctivitis—Epirubicin—sarcoma	0.00151	0.00793	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—sarcoma	0.00144	0.00755	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—sarcoma	0.0014	0.00734	CcSEcCtD
Cyclopentolate—Rash—Vincristine—sarcoma	0.00137	0.00723	CcSEcCtD
Cyclopentolate—Dermatitis—Vincristine—sarcoma	0.00137	0.00722	CcSEcCtD
Cyclopentolate—Rash—Mitoxantrone—sarcoma	0.00134	0.00704	CcSEcCtD
Cyclopentolate—Dermatitis—Mitoxantrone—sarcoma	0.00134	0.00703	CcSEcCtD
Cyclopentolate—Flushing—Epirubicin—sarcoma	0.00129	0.0068	CcSEcCtD
Cyclopentolate—Pruritus—Etoposide—sarcoma	0.00125	0.00657	CcSEcCtD
Cyclopentolate—Flushing—Doxorubicin—sarcoma	0.0012	0.00629	CcSEcCtD
Cyclopentolate—Vision blurred—Epirubicin—sarcoma	0.00114	0.00601	CcSEcCtD
Cyclopentolate—Agitation—Epirubicin—sarcoma	0.00111	0.00586	CcSEcCtD
Cyclopentolate—Rash—Etoposide—sarcoma	0.00111	0.00585	CcSEcCtD
Cyclopentolate—Dermatitis—Etoposide—sarcoma	0.00111	0.00585	CcSEcCtD
Cyclopentolate—Vertigo—Epirubicin—sarcoma	0.00109	0.00573	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—sarcoma	0.00106	0.00556	CcSEcCtD
Cyclopentolate—Convulsion—Epirubicin—sarcoma	0.00105	0.00553	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—sarcoma	0.00103	0.00542	CcSEcCtD
Cyclopentolate—Dry mouth—Epirubicin—sarcoma	0.00101	0.00531	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—sarcoma	0.00101	0.0053	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—sarcoma	0.000972	0.00511	CcSEcCtD
Cyclopentolate—Tachycardia—Epirubicin—sarcoma	0.000966	0.00508	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—sarcoma	0.000934	0.00491	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—sarcoma	0.000893	0.0047	CcSEcCtD
Cyclopentolate—Somnolence—Epirubicin—sarcoma	0.000879	0.00463	CcSEcCtD
Cyclopentolate—Somnolence—Doxorubicin—sarcoma	0.000814	0.00428	CcSEcCtD
Cyclopentolate—Pruritus—Epirubicin—sarcoma	0.0007	0.00368	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—sarcoma	0.000648	0.00341	CcSEcCtD
Cyclopentolate—Rash—Epirubicin—sarcoma	0.000624	0.00328	CcSEcCtD
Cyclopentolate—Dermatitis—Epirubicin—sarcoma	0.000623	0.00328	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—sarcoma	0.000577	0.00304	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—sarcoma	0.000577	0.00303	CcSEcCtD
